Yonhap Infomax NewsMay 21, 2025
US FDA initiates inspection of Samsung Biologics' production facilities in Incheon Songdo, focusing on Plants 3 and 4 as part of expanded overseas facility checks
#YonhapInfomax #USFDA #SamsungBiologics #ProductionFacilities #IncheonSongdo #RegulatoryOversight #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64145
US FDA Begins Inspection of Samsung Biologics' Production Facility in Incheon Songdo

US FDA initiates inspection of Samsung Biologics' production facilities in Incheon Songdo, focusing on Plants 3 and 4 as part of expanded overseas facility checks

Yonhap Infomax